Cholinergic Receptor Binding Profile of Hypericum Perforatum L. and Its Active Constituents
| dc.contributor.author | Hamurtekin, Emre | |
| dc.contributor.author | Hamurtekin, Y. | |
| dc.contributor.author | Matucci, R. | |
| dc.contributor.author | Dei, S. | |
| dc.contributor.author | Dayanç, Barış Emre | |
| dc.contributor.author | Kazdağlı, Hasan | |
| dc.date.accessioned | 2023-06-16T14:46:38Z | |
| dc.date.available | 2023-06-16T14:46:38Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | Background andObjective: Hypericum perforatum L (HP) is a popular herbal medicine with different pharmacological effects. This study investigated the possible cholinergic receptor affinities of HP extract and its three active constituents: hyperforin, hypericin and pseudohypericin. Materials and Methods: Radioactive compounds [3H]-N-methyl scopolamine used for muscarinic receptor binding studies in Chinese hamster ovary cells expressing human muscarinic receptor subtypes and [3H]-cytisine used for nicotinic receptor binding tests performed with mouse brains without a cerebellum. Muscarinic binding inhibition was observed with HP extract considerably for hM2 and hM5. Results: Hyperforin, hypericin and pseudohypericin showed a much lower affinity for muscarinic receptors at higher concentrations. The HP extract and its constituents did not produce any nicotinic receptor binding inhibition. Conclusion:These results suggested that post-junctional direct muscarinic receptor interaction may modulate some effects of HP extract and its constituents however different mechanisms apart from direct cholinergic receptor interaction might be considered for the pharmacological actions of hyperforin, hypericin and pseudohypericin. | en_US |
| dc.identifier.doi | 10.3923/ijp.2022.1429.1439 | |
| dc.identifier.issn | 1811-7775 | |
| dc.identifier.issn | 1812-5700 | |
| dc.identifier.uri | https://doi.org/10.3923/ijp.2022.1429.1439 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14365/2614 | |
| dc.language.iso | en | en_US |
| dc.publisher | Asian Network Scientific Information-Ansinet | en_US |
| dc.relation.ispartof | Internatıonal Journal of Pharmacology | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Hypericum perforatum L. | en_US |
| dc.subject | muscarinic receptors | en_US |
| dc.subject | nicotinic receptors | en_US |
| dc.subject | hyperforin | en_US |
| dc.subject | hypericin | en_US |
| dc.subject | pseudohypericin | en_US |
| dc.subject | St-Johns-Wort | en_US |
| dc.subject | Acetylcholine-Release | en_US |
| dc.subject | Hyperforin | en_US |
| dc.subject | Mechanism | en_US |
| dc.subject | Reveals | en_US |
| dc.subject | Extract | en_US |
| dc.subject | Bladder | en_US |
| dc.subject | Memory | en_US |
| dc.subject | Drug | en_US |
| dc.title | Cholinergic Receptor Binding Profile of Hypericum Perforatum L. and Its Active Constituents | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.author.id | Dei, Silvia/0000-0003-0898-7148 | |
| gdc.bip.impulseclass | C5 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C5 | |
| gdc.coar.access | open access | |
| gdc.coar.type | text::journal::journal article | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | İzmir Ekonomi Üniversitesi | en_US |
| gdc.description.departmenttemp | [Hamurtekin, E.; Hamurtekin, Y.] Eastern Mediterranean Univ, Fac Pharm, Dept Pharmacol, Via Mersin 10, Famagusta, North Cyprus, Turkey; [Matucci, R.; Dei, S.] Univ Florence, Sect Pharmaceut & Nutraceut Sci, Dept Neurosci Psychol Drug Res & Childs Hlth, Florence, Italy; [Baris, E.] Izmir Univ Econ, Fac Med, Dept Pharmacol, Izmir, Turkey; [Kazdagli, H.] Izmir Univ Econ, Vocat Sch Hlth Serv, Izmir, Turkey | en_US |
| gdc.description.endpage | 1439 | en_US |
| gdc.description.issue | 7 | en_US |
| gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | N/A | |
| gdc.description.startpage | 1429 | en_US |
| gdc.description.volume | 18 | en_US |
| gdc.description.wosquality | Q4 | |
| gdc.identifier.openalex | W4297168735 | |
| gdc.identifier.wos | WOS:000871581300010 | |
| gdc.index.type | WoS | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 0.0 | |
| gdc.oaire.influence | 2.4895952E-9 | |
| gdc.oaire.isgreen | true | |
| gdc.oaire.keywords | Hypericum perforatum L; muscarinic receptors; nicotinic receptors; hyperforin; hypericin; pseudohypericin | |
| gdc.oaire.popularity | 1.7808596E-9 | |
| gdc.oaire.publicfunded | false | |
| gdc.oaire.sciencefields | 0301 basic medicine | |
| gdc.oaire.sciencefields | 03 medical and health sciences | |
| gdc.oaire.sciencefields | 0302 clinical medicine | |
| gdc.openalex.collaboration | International | |
| gdc.openalex.fwci | 0.0 | |
| gdc.openalex.normalizedpercentile | 0.06 | |
| gdc.opencitations.count | 0 | |
| gdc.plumx.mendeley | 1 | |
| gdc.virtual.author | Dayanç, Barış Emre | |
| gdc.virtual.author | Kazdağlı, Hasan | |
| gdc.wos.citedcount | 0 | |
| relation.isAuthorOfPublication | d395a3ed-ea86-4351-8ac3-af9c3e9e7839 | |
| relation.isAuthorOfPublication | a0611b74-e150-42f0-840c-b1852675e467 | |
| relation.isAuthorOfPublication.latestForDiscovery | d395a3ed-ea86-4351-8ac3-af9c3e9e7839 | |
| relation.isOrgUnitOfPublication | 6fa0b57f-bcf5-480a-a53d-ac32b8e77edd | |
| relation.isOrgUnitOfPublication | 4cbb0a74-ee1a-438b-b714-b8ef253df94b | |
| relation.isOrgUnitOfPublication | 102d99a4-5f52-4392-af31-1ecf89cc7516 | |
| relation.isOrgUnitOfPublication | e9e77e3e-bc94-40a7-9b24-b807b2cd0319 | |
| relation.isOrgUnitOfPublication | fbc53f3e-d1d3-4168-afd8-e42cd20bddd9 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 6fa0b57f-bcf5-480a-a53d-ac32b8e77edd |
Files
Original bundle
1 - 1 of 1
